Volume 21: Issue 3 (Aug 2022): Transplantation

Akalin E, Azzi Y, Bartash R, Seethamraju H, Parides M, Hemmige V, et al.: Covid-19 and kidney transplantation. N Engl J Med 382: 2475–2477, 2020 10.1056/NEJMc2011117 PubMed

Akalin E, Azzi Y, Bartash R, Seethamraju H, Parides M, Hemmige V, : Covid-19 and kidney transplantation. N Engl J Med 382: 2475–2477, 2020 10.1056/NEJMc2011117 PubMed)| false
• Search Google Scholar
• Export Citation

Azzi Y, Parides M, Alani O, Loarte-Campos P, Bartash R, Forest S, et al.: COVID-19 infection in kidney transplant recipients at the epicenter of pandemics. Kidney Int 98: 1559–1567, 2020 10.1016/j.kint.2020.10.004 PubMed

Azzi Y, Parides M, Alani O, Loarte-Campos P, Bartash R, Forest S, : COVID-19 infection in kidney transplant recipients at the epicenter of pandemics. Kidney Int 98: 1559–1567, 2020 10.1016/j.kint.2020.10.004 PubMed)| false
• Search Google Scholar
• Export Citation

Nair V, Jandovitz N, Hirsch JS, Nair G, Abate M, Bhaskaran M, et al.: COVID-19 in kidney transplant recipients. Am J Transplant 20: 1819–1825, 2020 10.1111/ajt.15967 PubMed

Nair V, Jandovitz N, Hirsch JS, Nair G, Abate M, Bhaskaran M, : COVID-19 in kidney transplant recipients. Am J Transplant 20: 1819–1825, 2020 10.1111/ajt.15967 PubMed)| false
• Search Google Scholar
• Export Citation

Pereira MR, Mohan S, Cohen DJ, Husain SA, Dube GK, Ratner LE, et al.: COVID-19 in solid organ transplant recipients: Initial report from the US epicenter. Am J Transplant 20: 1800–1808, 2020 10.1111/ajt.15941 PubMed

Pereira MR, Mohan S, Cohen DJ, Husain SA, Dube GK, Ratner LE, : COVID-19 in solid organ transplant recipients: Initial report from the US epicenter. Am J Transplant 20: 1800–1808, 2020 10.1111/ajt.15941 PubMed)| false
• Search Google Scholar
• Export Citation

Lubetzky M, Aull MJ, Craig-Schapiro R, Lee JR, Marku-Podvorica J, Salinas T, et al.: Kidney allograft recipients, immunosuppression, and coronavirus disease-2019: A report of consecutive cases from a New York City transplant center. Nephrol Dial Transplant 35: 1250–1261, 2020 10.1093/ndt/gfaa154 PubMed

Lubetzky M, Aull MJ, Craig-Schapiro R, Lee JR, Marku-Podvorica J, Salinas T, : Kidney allograft recipients, immunosuppression, and coronavirus disease-2019: A report of consecutive cases from a New York City transplant center. Nephrol Dial Transplant 35: 1250–1261, 2020 10.1093/ndt/gfaa154 PubMed)| false
• Search Google Scholar
• Export Citation

Mehta SA, Leonard J, Labella P, Cartiera K, Soomro I, Neumann H, et al.: Outpatient management of kidney transplant recipients with suspected COVID-19-Single-center experience during the New York City surge. Transpl Infect Dis 22: e13383, 2020 10.1111/tid.13383 PubMed

Mehta SA, Leonard J, Labella P, Cartiera K, Soomro I, Neumann H, : Outpatient management of kidney transplant recipients with suspected COVID-19-Single-center experience during the New York City surge. Transpl Infect Dis 22: e13383, 2020 10.1111/tid.13383 PubMed)| false
• Search Google Scholar
• Export Citation

Cravedi P, Mothi SS, Azzi Y, Haverly M, Farouk SS, Pérez-Sáez MJ, et al.: COVID-19 and kidney transplantation: Results from the TANGO International Transplant Consortium. Am J Transplant 20: 3140–3148, 2020 10.1111/ajt.16185 PubMed

Cravedi P, Mothi SS, Azzi Y, Haverly M, Farouk SS, Pérez-Sáez MJ, : COVID-19 and kidney transplantation: Results from the TANGO International Transplant Consortium. Am J Transplant 20: 3140–3148, 2020 10.1111/ajt.16185 PubMed)| false
• Search Google Scholar
• Export Citation

Kates OS, Haydel BM, Florman SS, Rana MM, Chaudhry ZS, Ramesh MS, et al.; UW COVID-19 SOT Study Team: Coronavirus disease 2019 in solid organ transplant: A multicenter cohort study. Clin Infect Dis 73: e4090–e4099, 2021 10.1093/cid/ciaa1097 PubMed

Kates OS, Haydel BM, Florman SS, Rana MM, Chaudhry ZS, Ramesh MS, ; UW COVID-19 SOT Study Team: Coronavirus disease 2019 in solid organ transplant: A multicenter cohort study. Clin Infect Dis 73: e4090–e4099, 202110.1093/cid/ciaa1097 PubMed)| false
• Search Google Scholar
• Export Citation

Alberici F, Delbarba E, Manenti C, Econimo L, Valerio F, Pola A, et al.: A single center observational study of the clinical characteristics and short-term outcome of 20 kidney transplant patients admitted for SARS-CoV2 pneumonia. Kidney Int 97: 1083–1088, 2020 10.1016/j.kint.2020.04.002 PubMed

Alberici F, Delbarba E, Manenti C, Econimo L, Valerio F, Pola A, : A single center observational study of the clinical characteristics and short-term outcome of 20 kidney transplant patients admitted for SARS-CoV2 pneumonia. Kidney Int 97: 1083–1088, 2020 10.1016/j.kint.2020.04.002 PubMed)| false
• Search Google Scholar
• Export Citation

Bossini N, Alberici F, Delbarba E, Valerio F, Manenti C, Possenti S, et al.; Brescia Renal COVID task force: Kidney transplant patients with SARS-CoV-2 infection: The Brescia Renal COVID task force experience. Am J Transplant 20: 3019–3029, 2020 10.1111/ajt.16176 PubMed

Bossini N, Alberici F, Delbarba E, Valerio F, Manenti C, Possenti S, ; Brescia Renal COVID task force: Kidney transplant patients with SARS-CoV-2 infection: The Brescia Renal COVID task force experience. Am J Transplant 20: 3019–3029, 2020 10.1111/ajt.16176 PubMed)| false
• Search Google Scholar
• Export Citation

Caillard S, Anglicheau D, Matignon M, Durrbach A, Greze C, Frimat L, et al.; French SOT COVID Registry: An initial report from the French SOT COVID Registry suggests high mortality due to COVID-19 in recipients of kidney transplants. Kidney Int 98: 1549–1558, 2020 10.1016/j.kint.2020.08.005 PubMed

Caillard S, Anglicheau D, Matignon M, Durrbach A, Greze C, Frimat L, ; French SOT COVID Registry: An initial report from the French SOT COVID Registry suggests high mortality due to COVID-19 in recipients of kidney transplants. Kidney Int 98: 1549–1558, 2020 10.1016/j.kint.2020.08.005 PubMed)| false
• Search Google Scholar
• Export Citation

Crespo M, Pérez-Sáez MJ, Redondo-Pachón D, Llinàs-Mallol L, Montero MM, Villar-García J, et al.: COVID-19 in elderly kidney transplant recipients. Am J Transplant 20: 2883–2889, 2020 10.1111/ajt.16096 PubMed

Crespo M, Pérez-Sáez MJ, Redondo-Pachón D, Llinàs-Mallol L, Montero MM, Villar-García J, : COVID-19 in elderly kidney transplant recipients. Am J Transplant 20: 2883–2889, 2020 10.1111/ajt.16096 PubMed)| false
• Search Google Scholar
• Export Citation

Demir E, Uyar M, Parmaksiz E, Sinangil A, Yelken B, Dirim AB, et al.: COVID-19 in kidney transplant recipients: A multicenter experience in Istanbul. Transpl Infect Dis 22: e13371, 2020 10.1111/tid.13371 PubMed

Demir E, Uyar M, Parmaksiz E, Sinangil A, Yelken B, Dirim AB, : COVID-19 in kidney transplant recipients: A multicenter experience in Istanbul. Transpl Infect Dis 22: e13371, 2020 10.1111/tid.13371 PubMed)| false
• Search Google Scholar
• Export Citation

Elias M, Pievani D, Randoux C, Louis K, Denis B, Delion A, et al.: COVID-19 infection in kidney transplant recipients: Disease incidence and clinical outcomes. J Am Soc Nephrol 31: 2413–2423, 2020 10.1681/ASN.2020050639 PubMed

Elias M, Pievani D, Randoux C, Louis K, Denis B, Delion A, : COVID-19 infection in kidney transplant recipients: Disease incidence and clinical outcomes. J Am Soc Nephrol 31: 2413–2423, 2020 10.1681/ASN.2020050639 PubMed)| false
• Search Google Scholar
• Export Citation

Favà A, Cucchiari D, Montero N, Toapanta N, Centellas FJ, Vila-Santandreu A, et al.: Clinical characteristics and risk factors for severe COVID-19 in hospitalized kidney transplant recipients: A multicentric cohort study. Am J Transplant 20: 3030–3041, 2020 10.1111/ajt.16246 PubMed

Favà A, Cucchiari D, Montero N, Toapanta N, Centellas FJ, Vila-Santandreu A, : Clinical characteristics and risk factors for severe COVID-19 in hospitalized kidney transplant recipients: A multicentric cohort study. Am J Transplant 20: 3030–3041, 2020 10.1111/ajt.16246 PubMed)| false
• Search Google Scholar
• Export Citation

Sánchez-Álvarez JE, Pérez Fontán M, Jiménez Martín C, Blasco Pelícano M, Cabezas Reina CJ, Sevillano Prieto ÁM, et al.: SARS-CoV-2 infection in patients on renal replacement therapy. Report of the COVID-19 Registry of the Spanish Society of Nephrology (SEN). Nefrologia (Engl Ed) 40: 272–278, 2020 10.1016/j.nefro.2020.04.002 PubMed

Sánchez-Álvarez JE, Pérez Fontán M, Jiménez Martín C, Blasco Pelícano M, Cabezas Reina CJ, Sevillano Prieto ÁM, : SARS-CoV-2 infection in patients on renal replacement therapy. Report of the COVID-19 Registry of the Spanish Society of Nephrology (SEN). Nefrologia (Engl Ed) 40: 272–278, 2020 10.1016/j.nefro.2020.04.002 PubMed)| false
• Search Google Scholar
• Export Citation

Benotmane I, Perrin P, Vargas GG, Bassand X, Keller N, Lavaux T, et al.: Biomarkers of cytokine release syndrome predict disease severity and mortality from COVID-19 in kidney transplant recipients. Transplantation 105: 158–169, 2021 10.1097/TP.0000000000003480 PubMed

Benotmane I, Perrin P, Vargas GG, Bassand X, Keller N, Lavaux T, : Biomarkers of cytokine release syndrome predict disease severity and mortality from COVID-19 in kidney transplant recipients. Transplantation 105: 158–169, 2021 10.1097/TP.0000000000003480 PubMed)| false
• Search Google Scholar
• Export Citation

Ajaimy M, Liriano-Ward L, Graham JA, Akalin E: Risks and benefits of kidney transplantation during the COVID-19 pandemic: Transplant or not transplant? Kidney360 2: 1179–1187, 2021 PubMed

Ajaimy M, Liriano-Ward L, Graham JA, Akalin E: Risks and benefits of kidney transplantation during the COVID-19 pandemic: Transplant or not transplant? Kidney360 2: 1179–1187, 2021 PubMed)| false
• Search Google Scholar
• Export Citation

Azzi Y, Bartash R, Scalea J, Loarte-Campos P, Akalin E: COVID-19 and solid organ transplantation: A review article. Transplantation 105: 37–55, 2021 10.1097/TP.0000000000003523 PubMed

Azzi Y, Bartash R, Scalea J, Loarte-Campos P, Akalin E: COVID-19 and solid organ transplantation: A review article. Transplantation 105: 37–55, 2021 10.1097/TP.0000000000003523 PubMed)| false
• Search Google Scholar
• Export Citation

Yang W, Kandula S, Huynh M, Greene SK, Van Wye G, Li W, et al.: Estimating the infection-fatality risk of SARS-CoV-2 in New York City during the spring 2020 pandemic wave: A model-based analysis. Lancet Infect Dis 21: 203–212, 2021 10.1016/S1473-3099(20)30769-6 PubMed

Yang W, Kandula S, Huynh M, Greene SK, Van Wye G, Li W, : Estimating the infection-fatality risk of SARS-CoV-2 in New York City during the spring 2020 pandemic wave: A model-based analysis. Lancet Infect Dis 21: 203–212, 2021 10.1016/S1473-3099(20)30769-6 PubMed)| false
• Search Google Scholar
• Export Citation

Williamson EJ, Walker AJ, Bhaskaran K, Bacon S, Bates C, Morton CE, et al.: Factors associated with COVID-19-related death using OpenSAFELY. Nature 584: 430–436, 2020 10.1038/s41586-020-2521-4 PubMed

Williamson EJ, Walker AJ, Bhaskaran K, Bacon S, Bates C, Morton CE, : Factors associated with COVID-19-related death using OpenSAFELY. Nature 584: 430–436, 2020 10.1038/s41586-020-2521-4 PubMed)| false
• Search Google Scholar
• Export Citation

Perico L, Benigni A, Casiraghi F, Ng LFP, Renia L, Remuzzi G: Immunity, endothelial injury and complement-induced coagulopathy in COVID-19. Nat Rev Nephrol 17: 46–64, 2021 10.1038/s41581-020-00357-4 PubMed

Perico L, Benigni A, Casiraghi F, Ng LFP, Renia L, Remuzzi G: Immunity, endothelial injury and complement-induced coagulopathy in COVID-19. Nat Rev Nephrol 17: 46–64, 2021 10.1038/s41581-020-00357-4 PubMed)| false
• Search Google Scholar
• Export Citation

Ackermann M, Verleden SE, Kuehnel M, Haverich A, Welte T, Laenger F, et al.: Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. N Engl J Med 383: 120–128, 2020 10.1056/NEJMoa2015432 PubMed

Ackermann M, Verleden SE, Kuehnel M, Haverich A, Welte T, Laenger F, : Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. N Engl J Med 383: 120–128, 2020 10.1056/NEJMoa2015432 PubMed)| false
• Search Google Scholar
• Export Citation

Tang N, Li D, Wang X, Sun Z: Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost 18: 844–847, 2020 10.1111/jth.14768 PubMed

Tang N, Li D, Wang X, Sun Z: Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost 18: 844–847, 2020 10.1111/jth.14768 PubMed)| false
• Search Google Scholar
• Export Citation

Bae S, McAdams-DeMarco MA, Massie AB, Ahn JB, Werbel WA, Brennan DC, et al.: Early changes in kidney transplant immunosuppression regimens during the COVID-19 pandemic. Transplantation 105: 170–176, 2021 10.1097/TP.0000000000003502 PubMed

Bae S, McAdams-DeMarco MA, Massie AB, Ahn JB, Werbel WA, Brennan DC, : Early changes in kidney transplant immunosuppression regimens during the COVID-19 pandemic. Transplantation 105: 170–176, 2021 10.1097/TP.0000000000003502 PubMed)| false
• Search Google Scholar
• Export Citation

Thaunat O, Legeai C, Anglicheau D, Couzi L, Blancho G, Hazzan M, et al.; French nationwide Registry of Solid Organ Transplant Recipients with COVID-19: IMPact of the COVID-19 epidemic on the moRTAlity of kidney transplant recipients and candidates in a French Nationwide registry sTudy (IMPORTANT). Kidney Int 98: 1568–1577, 2020 10.1016/j.kint.2020.10.008 PubMed

Thaunat O, Legeai C, Anglicheau D, Couzi L, Blancho G, Hazzan M, ; French nationwide Registry of Solid Organ Transplant Recipients with COVID-19: IMPact of the COVID-19 epidemic on the moRTAlity of kidney transplant recipients and candidates in a French Nationwide registry sTudy (IMPORTANT). Kidney Int 98: 1568–1577, 2020 10.1016/j.kint.2020.10.008 PubMed)| false
• Search Google Scholar
• Export Citation

Angelico R, Blasi F, Manzia TM, Toti L, Tisone G, Cacciola R: The management of immunosuppression in kidney transplant recipients with COVID-19 disease: An update and systematic review of the literature. Medicina (Kaunas) 57: 435, 2021 10.3390/medicina57050435 PubMed

Angelico R, Blasi F, Manzia TM, Toti L, Tisone G, Cacciola R: The management of immunosuppression in kidney transplant recipients with COVID-19 disease: An update and systematic review of the literature. Medicina (Kaunas) 57: 435, 2021 10.3390/medicina57050435 PubMed)| false
• Search Google Scholar
• Export Citation

Moosavi SA, Mashhadiagha A, Motazedian N, Hashemazar A, Hoveidaei AH, Bolignano D: COVID-19 clinical manifestations and treatment strategies among solid-organ recipients: A systematic review of cases. Transpl Infect Dis 22: e13427, 2020 10.1111/tid.13427 PubMed

Moosavi SA, Mashhadiagha A, Motazedian N, Hashemazar A, Hoveidaei AH, Bolignano D: COVID-19 clinical manifestations and treatment strategies among solid-organ recipients: A systematic review of cases. Transpl Infect Dis 22: e13427, 2020 10.1111/tid.13427 PubMed)| false
• Search Google Scholar
• Export Citation

Marinaki S, Tsiakas S, Korogiannou M, Grigorakos K, Papalois V, Boletis I: A systematic review of COVID-19 infection in kidney transplant recipients: A universal effort to preserve patients’ lives and allografts. J Clin Med 9: E2986, 2020 10.3390/jcm9092986 PubMed

Marinaki S, Tsiakas S, Korogiannou M, Grigorakos K, Papalois V, Boletis I: A systematic review of COVID-19 infection in kidney transplant recipients: A universal effort to preserve patients’ lives and allografts. J Clin Med 9: E2986, 2020 10.3390/jcm9092986 PubMed)| false
• Search Google Scholar
• Export Citation

Daniel E, Sekulic M, Kudose S, Kubin C, Ye X, Shayan K, et al.: Kidney allograft biopsy findings after COVID-19. Am J Transplant 21: 4032–4042, 2021 10.1111/ajt.16804 PubMed

Daniel E, Sekulic M, Kudose S, Kubin C, Ye X, Shayan K, : Kidney allograft biopsy findings after COVID-19. Am J Transplant 21: 4032–4042, 2021 10.1111/ajt.16804 PubMed)| false
• Search Google Scholar
• Export Citation

Masset C, Gautier-Vargas G, Cantarovich D, Ville S, Dantal J, Delbos F, et al.: Occurrence of de novo donor specific antibodies after Covid-19 in kidney transplant recipients is low despite immunosuppression modulation. Kidney Int Rep 7: 983–992, 2022 10.1016/j.ekir.2022.01.1072 PubMed

Masset C, Gautier-Vargas G, Cantarovich D, Ville S, Dantal J, Delbos F, : Occurrence of de novo donor specific antibodies after Covid-19 in kidney transplant recipients is low despite immunosuppression modulation. Kidney Int Rep 7: 983–992, 2022 10.1016/j.ekir.2022.01.1072 PubMed)| false
• Search Google Scholar
• Export Citation

Beigel JH, Tomashek KM, Dodd LE: Remdesivir for the treatment of Covid-19—preliminary report. Reply. N Engl J Med 383: 994, 2020 10.1056/NEJMoa2007764 PubMed

Beigel JH, Tomashek KM, Dodd LE: Remdesivir for the treatment of Covid-19—preliminary report. Reply. N Engl J Med 383: 994, 2020 10.1056/NEJMoa2007764 PubMed)| false
• Search Google Scholar
• Export Citation

Buxeda A, Arias-Cabrales C, Pérez-Sáez MJ, Cacho J, Cabello Pelegrin S, Melilli E, et al.: Use and safety of remdesivir in kidney transplant recipients with COVID-19. Kidney Int Rep 6: 2305–2315, 2021 10.1016/j.ekir.2021.06.023 PubMed

Buxeda A, Arias-Cabrales C, Pérez-Sáez MJ, Cacho J, Cabello Pelegrin S, Melilli E, : Use and safety of remdesivir in kidney transplant recipients with COVID-19. Kidney Int Rep 6: 2305–2315, 2021 10.1016/j.ekir.2021.06.023 PubMed)| false
• Search Google Scholar
• Export Citation

Meshram HS, Kute VB, Patel H, Banerjee S, Navadiya V, Desai S, et al.: Feasibility and safety of remdesivir in SARS-CoV2 infected renal transplant recipients: A retrospective cohort from a developing nation. Transpl Infect Dis 23: e13629, 2021 10.1111/tid.13629 PubMed

Meshram HS, Kute VB, Patel H, Banerjee S, Navadiya V, Desai S, : Feasibility and safety of remdesivir in SARS-CoV2 infected renal transplant recipients: A retrospective cohort from a developing nation. Transpl Infect Dis 23: e13629, 2021 10.1111/tid.13629 PubMed)| false
• Search Google Scholar
• Export Citation

Group RC; RECOVERY Collaborative Group: Lopinavir-ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): A randomised, controlled, open-label, platform trial. Lancet 396: 1345–1352, 2020 10.1016/S0140-6736(20)32013-4 PubMed

Group RC; RECOVERY Collaborative Group: Lopinavir-ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): A randomised, controlled, open-label, platform trial. Lancet 396: 1345–1352, 2020 10.1016/S0140-6736(20)32013-4 PubMed)| false
• Search Google Scholar
• Export Citation

Pan H, Peto R, Henao-Restrepo AM, Preziosi MP, Sathiyamoorthy V, Abdool Karim Q, et al.; WHO Solidarity Trial Consortium: Repurposed antiviral drugs for Covid-19—interim WHO solidarity trial results. N Engl J Med 384: 497–511, 2021 10.1056/NEJMoa2023184 PubMed

Pan H, Peto R, Henao-Restrepo AM, Preziosi MP, Sathiyamoorthy V, Abdool Karim Q, ; WHO Solidarity Trial Consortium: Repurposed antiviral drugs for Covid-19—interim WHO solidarity trial results. N Engl J Med 384: 497–511, 2021 10.1056/NEJMoa2023184 PubMed)| false
• Search Google Scholar
• Export Citation

Wen W, Chen C, Tang J, Wang C, Zhou M, Cheng Y, et al.: Efficacy and safety of three new oral antiviral treatment (molnupiravir, fluvoxamine and Paxlovid) for COVID-19: A meta-analysis. Ann Med 54: 516–523, 2022 10.1080/07853890.2022.2034936 PubMed

Wen W, Chen C, Tang J, Wang C, Zhou M, Cheng Y, : Efficacy and safety of three new oral antiviral treatment (molnupiravir, fluvoxamine and Paxlovid) for COVID-19: A meta-analysis. Ann Med 54: 516–523, 2022 10.1080/07853890.2022.2034936 PubMed)| false
• Search Google Scholar
• Export Citation

Horby P, Lim WS, Emberson JR, Mafham M, Bell JL, Linsell L, et al.; RECOVERY Collaborative Group: Dexamethasone in hospitalized patients with Covid-19. N Engl J Med 384: 693–704, 2021 10.1056/NEJMoa2021436 PubMed

Horby P, Lim WS, Emberson JR, Mafham M, Bell JL, Linsell L, ; RECOVERY Collaborative Group: Dexamethasone in hospitalized patients with Covid-19. N Engl J Med 384: 693–704, 2021 10.1056/NEJMoa2021436 PubMed)| false
• Search Google Scholar
• Export Citation

Sterne JAC, Murthy S, Diaz JV, Slutsky AS, Villar J, Angus DC, et al.; WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group: Association between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19: A meta-analysis. JAMA 324: 1330–1341, 2020 10.1001/jama.2020.17023 PubMed

Sterne JAC, Murthy S, Diaz JV, Slutsky AS, Villar J, Angus DC, ; WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group: Association between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19: A meta-analysis. JAMA 324: 1330–1341, 2020 10.1001/jama.2020.17023 PubMed)| false
• Search Google Scholar
• Export Citation

Food and Drug Administration: Emergency Use Authorizations, 2022. Available at: https://www.fda.gov/emergency-preparedness-and-response/mcm-legal-regulatory-and-policy-framework/emergency-use-authorization#coviddrugs. Accessed July 20, 2022

Mahroum N, Watad A, Bridgewood C, Mansour M, Nasr A, Hussein A, et al.: Systematic review and meta-analysis of tocilizumab therapy versus standard of care in over 15,000 COVID-19 pneumonia patients during the first eight months of the pandemic. Int J Environ Res Public Health 18: 9149, 2021 10.3390/ijerph18179149 PubMed

Mahroum N, Watad A, Bridgewood C, Mansour M, Nasr A, Hussein A, : Systematic review and meta-analysis of tocilizumab therapy versus standard of care in over 15,000 COVID-19 pneumonia patients during the first eight months of the pandemic. Int J Environ Res Public Health 18: 9149, 2021 10.3390/ijerph18179149 PubMed)| false
• Search Google Scholar
• Export Citation

Bodro M, Cofan F, Ríos J, Herrera S, Linares L, Marcos MA, et al.: Use of anti-cytokine therapy in kidney transplant recipients with COVID-19. J Clin Med 10: 1551, 2021 10.3390/jcm10081551 PubMed

Bodro M, Cofan F, Ríos J, Herrera S, Linares L, Marcos MA, : Use of anti-cytokine therapy in kidney transplant recipients with COVID-19. J Clin Med 10: 1551, 2021 10.3390/jcm10081551 PubMed)| false
• Search Google Scholar
• Export Citation

Pereira MR, Aversa MM, Farr MA, Miko BA, Aaron JG, Mohan S, et al.: Tocilizumab for severe COVID-19 in solid organ transplant recipients: A matched cohort study. Am J Transplant 20: 3198–3205, 2020 10.1111/ajt.16314 PubMed

Pereira MR, Aversa MM, Farr MA, Miko BA, Aaron JG, Mohan S, : Tocilizumab for severe COVID-19 in solid organ transplant recipients: A matched cohort study. Am J Transplant 20: 3198–3205, 2020 10.1111/ajt.16314 PubMed)| false
• Search Google Scholar
• Export Citation

Pérez-Sáez MJ, Blasco M, Redondo-Pachón D, Ventura-Aguiar P, Bada-Bosch T, Pérez-Flores I, et al.; Spanish Society of Nephrology COVID-19 Group: Use of tocilizumab in kidney transplant recipients with COVID-19. Am J Transplant 20: 3182–3190, 2020 10.1111/ajt.16192 PubMed

Pérez-Sáez MJ, Blasco M, Redondo-Pachón D, Ventura-Aguiar P, Bada-Bosch T, Pérez-Flores I, ; Spanish Society of Nephrology COVID-19 Group: Use of tocilizumab in kidney transplant recipients with COVID-19. Am J Transplant 20: 3182–3190, 2020 10.1111/ajt.16192 PubMed)| false
• Search Google Scholar
• Export Citation

Khan FA, Stewart I, Fabbri L, Moss S, Robinson K, Smyth AR, et al.: Systematic review and meta-analysis of anakinra, sarilumab, siltuximab and tocilizumab for COVID-19. Thorax 76: 907–919, 2021 10.1136/thoraxjnl-2020-215266 PubMed

Khan FA, Stewart I, Fabbri L, Moss S, Robinson K, Smyth AR, : Systematic review and meta-analysis of anakinra, sarilumab, siltuximab and tocilizumab for COVID-19. Thorax 76: 907–919, 2021 10.1136/thoraxjnl-2020-215266 PubMed)| false
• Search Google Scholar
• Export Citation

Weinreich DM, Sivapalasingam S, Norton T, Ali S, Gao H, Bhore R, et al.; Trial Investigators: REGN-COV2, a neutralizing antibody cocktail, in outpatients with Covid-19. N Engl J Med 384: 238–251, 2021 10.1056/NEJMoa2035002 PubMed

Weinreich DM, Sivapalasingam S, Norton T, Ali S, Gao H, Bhore R, ; Trial Investigators: REGN-COV2, a neutralizing antibody cocktail, in outpatients with Covid-19. N Engl J Med 384: 238–251, 2021 10.1056/NEJMoa2035002 PubMed)| false
• Search Google Scholar
• Export Citation

Dougan M, Nirula A, Azizad M, Mocherla B, Gottlieb RL, Chen P, et al.; BLAZE-1 Investigators: Bamlanivimab plus etesevimab in mild or moderate Covid-19. N Engl J Med 385: 1382–1392, 2021 10.1056/NEJMoa2102685 PubMed

Dougan M, Nirula A, Azizad M, Mocherla B, Gottlieb RL, Chen P, ; BLAZE-1 Investigators: Bamlanivimab plus etesevimab in mild or moderate Covid-19. N Engl J Med 385: 1382–1392, 2021 10.1056/NEJMoa2102685 PubMed)| false
• Search Google Scholar
• Export Citation

Dhand A, Lobo SA, Wolfe K, Feola N, Lee L, Nog R, et al.: Casirivimab-imdevimab for treatment of COVID-19 in solid organ transplant recipients: An early experience. Transplantation 105: e68–e69, 2021 10.1097/TP.0000000000003737 PubMed

Dhand A, Lobo SA, Wolfe K, Feola N, Lee L, Nog R, : Casirivimab-imdevimab for treatment of COVID-19 in solid organ transplant recipients: An early experience. Transplantation 105: e68–e69, 2021 10.1097/TP.0000000000003737 PubMed)| false
• Search Google Scholar
• Export Citation

Liu EC, Lee JH, Loo A, Mazur S, Sultan S, Aull M, et al.: Casirivimab-imdevimab (REGN-COV2) for mild to moderate SARS-CoV-2 infection in kidney transplant recipients. Kidney Int Rep 6: 2900–2902, 2021 10.1016/j.ekir.2021.08.032 PubMed

Liu EC, Lee JH, Loo A, Mazur S, Sultan S, Aull M, : Casirivimab-imdevimab (REGN-COV2) for mild to moderate SARS-CoV-2 infection in kidney transplant recipients. Kidney Int Rep 6: 2900–2902, 2021 10.1016/j.ekir.2021.08.032 PubMed)| false
• Search Google Scholar
• Export Citation

Westendorf K, Žentelis S, Wang L, Foster D, Vaillancourt P, Wiggin M, et al.: LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants. Cell Rep 39: 110812, 2022 10.1101/2021.04.30.442182

Westendorf K, Žentelis S, Wang L, Foster D, Vaillancourt P, Wiggin M, : LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants. Cell Rep 39: 110812, 2022 10.1101/2021.04.30.442182)| false
• Search Google Scholar
• Export Citation

Kalil AC, Patterson TF, Mehta AK, Tomashek KM, Wolfe CR, Ghazaryan V, et al.; ACTT-2 Study Group Members: Baricitinib plus remdesivir for hospitalized adults with Covid-19. N Engl J Med 384: 795–807, 2021 10.1056/NEJMoa2031994 PubMed

Kalil AC, Patterson TF, Mehta AK, Tomashek KM, Wolfe CR, Ghazaryan V, ; ACTT-2 Study Group Members: Baricitinib plus remdesivir for hospitalized adults with Covid-19. N Engl J Med 384: 795–807, 2021 10.1056/NEJMoa2031994 PubMed)| false
• Search Google Scholar
• Export Citation

Janiaud P, Axfors C, Schmitt AM, Gloy V, Ebrahimi F, Hepprich M, et al.: Association of convalescent plasma treatment with clinical outcomes in patients with COVID-19: A systematic review and meta-analysis. JAMA 325: 1185–1195, 2021 10.1001/jama.2021.2747 PubMed

Janiaud P, Axfors C, Schmitt AM, Gloy V, Ebrahimi F, Hepprich M, : Association of convalescent plasma treatment with clinical outcomes in patients with COVID-19: A systematic review and meta-analysis. JAMA 325: 1185–1195, 2021 10.1001/jama.2021.2747 PubMed)| false
• Search Google Scholar
• Export Citation

Hueso T, Pouderoux C, Péré H, Beaumont AL, Raillon LA, Ader F, et al.: Convalescent plasma therapy for B-cell-depleted patients with protracted COVID-19. Blood 136: 2290–2295, 2020 10.1182/blood.2020008423 PubMed

Hueso T, Pouderoux C, Péré H, Beaumont AL, Raillon LA, Ader F, : Convalescent plasma therapy for B-cell-depleted patients with protracted COVID-19. Blood 136: 2290–2295, 2020 10.1182/blood.2020008423 PubMed)| false
• Search Google Scholar
• Export Citation

Gharbharan A, Jordan C, Anas AA, Bogers A, Geurts van Kessel CH, Rokx C, et al.: Treatment of COVID-19 in 22 B-Cell–Depleted Patients, 2021. Available at: https://www.croiconference.org/abstract/treatment-of-covid-19-in-22-b-cell-depleted-patients/. Accessed July 20, 2022

Senefeld JW, Klassen SA, Ford SK, Senese KA, Wiggins CC, Bostrom BC, et al.: Use of convalescent plasma in COVID-19 patients with immunosuppression. Transfusion 61: 2503–2511, 2021 10.1111/trf.16525 PubMed

Senefeld JW, Klassen SA, Ford SK, Senese KA, Wiggins CC, Bostrom BC, : Use of convalescent plasma in COVID-19 patients with immunosuppression. Transfusion 61: 2503–2511, 2021 10.1111/trf.16525 PubMed)| false
• Search Google Scholar
• Export Citation

Gupta A, Kute VB, Patel HV, Engineer DP, Banerjee S, Modi PR, et al.: Feasibility of convalescent plasma therapy in kidney transplant recipients with severe COVID-19: A single-center prospective cohort study. Exp Clin Transplant 19: 304–309, 2021 10.6002/ect.2020.0479 PubMed

Gupta A, Kute VB, Patel HV, Engineer DP, Banerjee S, Modi PR, : Feasibility of convalescent plasma therapy in kidney transplant recipients with severe COVID-19: A single-center prospective cohort study. Exp Clin Transplant 19: 304–309, 2021 10.6002/ect.2020.0479 PubMed)| false
• Search Google Scholar
• Export Citation

Eze P, Mezue KN, Nduka CU, Obianyo I, Egbuche O: Efficacy and safety of chloroquine and hydroxychloroquine for treatment of COVID-19 patients: A systematic review and meta-analysis of randomized controlled trials. Am J Cardiovasc Dis 11: 93–107, 2021 PubMed

Eze P, Mezue KN, Nduka CU, Obianyo I, Egbuche O: Efficacy and safety of chloroquine and hydroxychloroquine for treatment of COVID-19 patients: A systematic review and meta-analysis of randomized controlled trials. Am J Cardiovasc Dis 11: 93–107, 2021 PubMed)| false
• Search Google Scholar
• Export Citation

Self WH, Semler MW, Leither LM, Casey JD, Angus DC, Brower RG, et al.; National Heart, Lung, and Blood Institute PETAL Clinical Trials Network: Effect of hydroxychloroquine on clinical status at 14 days in hospitalized patients with COVID-19: A randomized clinical trial. JAMA 324: 2165–2176, 2020 10.1001/jama.2020.22240 PubMed

Self WH, Semler MW, Leither LM, Casey JD, Angus DC, Brower RG, ; National Heart, Lung, and Blood Institute PETAL Clinical Trials Network: Effect of hydroxychloroquine on clinical status at 14 days in hospitalized patients with COVID-19: A randomized clinical trial. JAMA 324: 2165–2176, 2020 10.1001/jama.2020.22240 PubMed)| false
• Search Google Scholar
• Export Citation

Popp M, Stegemann M, Metzendorf MI, Gould S, Kranke P, Meybohm P, et al.: Ivermectin for preventing and treating COVID-19. Cochrane Database Syst Rev 7: CD015017, 2021 10.1002/14651858.CD015017.pub2 PubMed

Popp M, Stegemann M, Metzendorf MI, Gould S, Kranke P, Meybohm P, : Ivermectin for preventing and treating COVID-19. Cochrane Database Syst Rev 7: CD015017, 2021 10.1002/14651858.CD015017.pub2 PubMed)| false
• Search Google Scholar
• Export Citation

Benotmane I, Gautier-Vargas G, Cognard N, Olagne J, Heibel F, Braun-Parvez L, et al.: Low immunization rates among kidney transplant recipients who received 2 doses of the mRNA-1273 SARS-CoV-2 vaccine. Kidney Int 99: 1498–1500, 2021 10.1016/j.kint.2021.04.005 PubMed

Benotmane I, Gautier-Vargas G, Cognard N, Olagne J, Heibel F, Braun-Parvez L, : Low immunization rates among kidney transplant recipients who received 2 doses of the mRNA-1273 SARS-CoV-2 vaccine. Kidney Int 99: 1498–1500, 2021 10.1016/j.kint.2021.04.005 PubMed)| false
• Search Google Scholar
• Export Citation

Cucchiari D, Egri N, Bodro M, Herrera S, Del Risco-Zevallos J, Casals-Urquiza J, et al.: Cellular and humoral response after MRNA-1273 SARS-CoV-2 vaccine in kidney transplant recipients. Am J Transplant 21: 2727–2739, 2021 10.1111/ajt.16701 PubMed

Cucchiari D, Egri N, Bodro M, Herrera S, Del Risco-Zevallos J, Casals-Urquiza J, : Cellular and humoral response after MRNA-1273 SARS-CoV-2 vaccine in kidney transplant recipients. Am J Transplant 21: 2727–2739, 2021 10.1111/ajt.16701 PubMed)| false
• Search Google Scholar
• Export Citation

Grupper A, Katchman H: Reduced humoral response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virus: Not alarming, but should be taken gravely. Am J Transplant 21: 2909, 2021 10.1111/ajt.16710 PubMed

Grupper A, Katchman H: Reduced humoral response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virus: Not alarming, but should be taken gravely. Am J Transplant 21: 2909, 2021 10.1111/ajt.16710 PubMed)| false
• Search Google Scholar
• Export Citation

Boyarsky BJ, Werbel WA, Avery RK, Tobian AAR, Massie AB, Segev DL, et al.: Antibody response to 2-dose SARS-CoV-2 mRNA Vaccine series in solid organ transplant recipients. JAMA 325: 2204–2206, 2021 10.1001/jama.2021.7489 PubMed

Boyarsky BJ, Werbel WA, Avery RK, Tobian AAR, Massie AB, Segev DL, : Antibody response to 2-dose SARS-CoV-2 mRNA Vaccine series in solid organ transplant recipients. JAMA 325: 2204–2206, 2021 10.1001/jama.2021.7489 PubMed)| false
• Search Google Scholar
• Export Citation

Dagan N, Barda N, Kepten E, Miron O, Perchik S, Katz MA, et al.: BNT162b2 mRNA Covid-19 vaccine in a nationwide mass vaccination setting. N Engl J Med 384: 1412–1423, 2021 10.1056/NEJMoa2101765 PubMed

Dagan N, Barda N, Kepten E, Miron O, Perchik S, Katz MA, : BNT162b2 mRNA Covid-19 vaccine in a nationwide mass vaccination setting. N Engl J Med 384: 1412–1423, 2021 10.1056/NEJMoa2101765 PubMed)| false
• Search Google Scholar
• Export Citation

Bertrand D, Hamzaoui M, Lemée V, Lamulle J, Hanoy M, Laurent C, et al.: Antibody and T cell response to SARS-CoV-2 messenger RNA BNT162b2 vaccine in kidney transplant recipients and hemodialysis patients. J Am Soc Nephrol 32: 2147–2152, 2021 10.1681/ASN.2021040480 PubMed

Bertrand D, Hamzaoui M, Lemée V, Lamulle J, Hanoy M, Laurent C, : Antibody and T cell response to SARS-CoV-2 messenger RNA BNT162b2 vaccine in kidney transplant recipients and hemodialysis patients. J Am Soc Nephrol 32: 2147–2152, 2021 10.1681/ASN.2021040480 PubMed)| false
• Search Google Scholar
• Export Citation

Sattler A, Schrezenmeier E, Weber UA, Potekhin A, Bachmann F, Straub-Hohenbleicher H, et al.: Impaired humoral and cellular immunity after SARS-CoV-2 BNT162b2 (tozinameran) prime-boost vaccination in kidney transplant recipients. J Clin Invest 131: 150175, 2021 10.1172/JCI150175 PubMed

Sattler A, Schrezenmeier E, Weber UA, Potekhin A, Bachmann F, Straub-Hohenbleicher H, : Impaired humoral and cellular immunity after SARS-CoV-2 BNT162b2 (tozinameran) prime-boost vaccination in kidney transplant recipients. J Clin Invest 131: 150175, 2021 10.1172/JCI150175 PubMed)| false
• Search Google Scholar
• Export Citation

Azzi Y, Raees H, Wang T, Cleare L, Liriano-Ward L, Loarte-Campos P, et al.: Risk factors associated with poor response to COVID-19 vaccination in kidney transplant recipients. Kidney Int 100: 1127–1128, 2021 10.1016/j.kint.2021.08.019 PubMed

Azzi Y, Raees H, Wang T, Cleare L, Liriano-Ward L, Loarte-Campos P, : Risk factors associated with poor response to COVID-19 vaccination in kidney transplant recipients. Kidney Int 100: 1127–1128, 2021 10.1016/j.kint.2021.08.019 PubMed)| false
• Search Google Scholar
• Export Citation

Werbel WA, Boyarsky BJ, Ou MT, Massie AB, Tobian AAR, Garonzik-Wang JM, et al.: Safety and immunogenicity of a third dose of SARS-CoV-2 vaccine in solid organ transplant recipients: A case series. Ann Intern Med 174: 1330–1332, 2021 10.7326/L21-0282 PubMed

Werbel WA, Boyarsky BJ, Ou MT, Massie AB, Tobian AAR, Garonzik-Wang JM, : Safety and immunogenicity of a third dose of SARS-CoV-2 vaccine in solid organ transplant recipients: A case series. Ann Intern Med 174: 1330–1332, 2021 10.7326/L21-0282 PubMed)| false
• Search Google Scholar
• Export Citation

Hall VG, Ferreira VH, Ku T, Ierullo M, Majchrzak-Kita B, Chaparro C, et al.: Randomized trial of a third dose of mRNA-1273 vaccine in transplant recipients. N Engl J Med 385: 1244–1246, 2021 10.1056/NEJMc2111462 PubMed

Hall VG, Ferreira VH, Ku T, Ierullo M, Majchrzak-Kita B, Chaparro C, : Randomized trial of a third dose of mRNA-1273 vaccine in transplant recipients. N Engl J Med 385: 1244–1246, 2021 10.1056/NEJMc2111462 PubMed)| false
• Search Google Scholar
• Export Citation

Centers for Disease Control and Prevention: COVID-19 Vaccines for People Who are Moderately or Severely Immunocompromised, 2022. Available at: https://www.cdc.gov/coronavirus/2019-ncov/vaccines/recommendations/immuno.html. Accessed July 20, 2022

ClinicalTrials.gov: Phase III Double-Blind, Placebo-Controlled Study of AZD7442 for Pre-Exposure Prophylaxis of COVID-19 in Adult. (PROVENT), 2022. Available at: https://clinicaltrials.gov/ct2/show/NCT04625725. Accessed July 20, 2022

Lentine KL, Mannon RB, Josephson MA: Practicing with uncertainty: Kidney transplantation during the COVID-19 pandemic. Am J Kidney Dis 77: 777–785, 2021 10.1053/j.ajkd.2020.12.003 PubMed

Lentine KL, Mannon RB, Josephson MA: Practicing with uncertainty: Kidney transplantation during the COVID-19 pandemic. Am J Kidney Dis 77: 777–785, 2021 10.1053/j.ajkd.2020.12.003 PubMed)| false
• Search Google Scholar
• Export Citation

Boyarsky BJ, Po-Yu Chiang T, Werbel WA, Durand CM, Avery RK, Getsin SN, et al.: Early impact of COVID-19 on transplant center practices and policies in the United States. Am J Transplant 20: 1809–1818, 2020 10.1111/ajt.15915 PubMed

Boyarsky BJ, Po-Yu Chiang T, Werbel WA, Durand CM, Avery RK, Getsin SN, : Early impact of COVID-19 on transplant center practices and policies in the United States. Am J Transplant 20: 1809–1818, 2020 10.1111/ajt.15915 PubMed)| false
• Search Google Scholar
• Export Citation

Loupy A, Aubert O, Reese PP, Bastien O, Bayer F, Jacquelinet C: Organ procurement and transplantation during the COVID-19 pandemic. Lancet 395: e95–e96, 2020 10.1016/S0140-6736(20)31040-0 PubMed

Loupy A, Aubert O, Reese PP, Bastien O, Bayer F, Jacquelinet C: Organ procurement and transplantation during the COVID-19 pandemic. Lancet 395: e95–e96, 2020 10.1016/S0140-6736(20)31040-0 PubMed)| false
• Search Google Scholar
• Export Citation

Manara AR, Mumford L, Callaghan CJ, Ravanan R, Gardiner D: Donation and transplantation activity in the UK during the COVID-19 lockdown. Lancet 396: 465–466, 2020 10.1016/S0140-6736(20)31692-5 PubMed

Manara AR, Mumford L, Callaghan CJ, Ravanan R, Gardiner D: Donation and transplantation activity in the UK during the COVID-19 lockdown. Lancet 396: 465–466, 2020 10.1016/S0140-6736(20)31692-5 PubMed)| false
• Search Google Scholar
• Export Citation

de Vries APJ, Alwayn IPJ, Hoek RAS, van den Berg AP, Ultee FCW, Vogelaar SM, et al.: Immediate impact of COVID-19 on transplant activity in the Netherlands. Transpl Immunol 61: 101304, 2020 10.1016/j.trim.2020.101304 PubMed

de Vries APJ, Alwayn IPJ, Hoek RAS, van den Berg AP, Ultee FCW, Vogelaar SM, : Immediate impact of COVID-19 on transplant activity in the Netherlands. Transpl Immunol 61: 101304, 2020 10.1016/j.trim.2020.101304 PubMed)| false
• Search Google Scholar
• Export Citation

Cholankeril G, Podboy A, Alshuwaykh OS, Kim D, Kanwal F, Esquivel CO, et al.: Early impact of COVID-19 on solid organ transplantation in the United States. Transplantation 104: 2221–2224, 2020 10.1097/TP.0000000000003391 PubMed

Cholankeril G, Podboy A, Alshuwaykh OS, Kim D, Kanwal F, Esquivel CO, : Early impact of COVID-19 on solid organ transplantation in the United States. Transplantation 104: 2221–2224, 2020 10.1097/TP.0000000000003391 PubMed)| false
• Search Google Scholar
• Export Citation

Boyarsky BJ, Werbel WA, Durand CM, Avery RK, Jackson KR, Kernodle AB, et al.: Early national and center-level changes to kidney transplantation in the United States during the COVID-19 epidemic. Am J Transplant 20: 3131–3139, 2020 10.1111/ajt.16167 PubMed